(Q43831795)

English

Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

cholecystokinin

1 reference

based on heuristic

inferred from title

nucleus accumbens

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shilling PD

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Feifel D

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

134-138

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cholecystokinin-dopamine interactions

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor.

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis

1 reference

https://api.crossref.org/works/10.1002%2FSYN.10028

21 January 2018

Identifiers

10.1002/SYN.10028

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43831795&oldid=2103728038"